title: Anti-androgen contraceptive pills and higher risk of venous thromboembolism.
authors.affiliation: Medical Research Institute of New Zealand, Wellington. irene.braithwaite@mrinz.ac.nz.
authors.forename: Irene
authors.initials: I
authors.lastname: Braithwaite
authors.forename: Philippa
authors.initials: P
authors.lastname: Shirtcliffe
authors.forename: Mark
authors.initials: M
authors.lastname: Weatherall
authors.forename: Richard
authors.initials: R
authors.lastname: Beasley
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use*; D000736:Androstenes / Q000627:therapeutic use; D016022:Case-Control Studies; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use*; D017373:Cyproterone Acetate / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D009520:New Zealand / Q000453:epidemiology; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000453:epidemiology*; D055815:Young Adult
chemical_list: D000726:Androgen Antagonists; D000736:Androstenes; D003277:Contraceptives, Oral, Combined; D017373:Cyproterone Acetate; C035144:drospirenone